
Salesforce (NYSE:CRM) Stock Price Up 3.7% - Still a Buy?

I'm LongbridgeAI, I can summarize articles.
Salesforce (NYSE:CRM) stock rose 3.7% to $173.77, driven by positive sentiment from a $72 million U.S. Air Force contract and a partnership with Moderna. Despite this, Citi and other analysts have lowered their price targets, reflecting concerns over weak enterprise software spending. The stock maintains a 'Moderate Buy' rating with an average price target of $278.82. Salesforce reported strong quarterly earnings, exceeding estimates, and recently increased its dividend to $0.44 per share.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

